Prevention of β-thalassemia in a large pakistani family through cascade testing

Community Genetics

Volumn 11, Issue 1, 2008, Pages 68-70

  Baig, S M ^a   Din, M A ^a   Hassan, H ^a   Azhar, A ^a   Baig, J M ^a   Aslam, M ^a   Anjum, I ^a   Farooq, M ^a   Hussain, M S ^a   Rasool, M ^a   Nawaz, S ^a   Qureshi, J A ^a   Zaman, T ^a  

^a NATIONAL INSTITUTE FOR BIOTECHNOLOGY AND GENETIC ENGINEERING NIBGE   (Pakistan)

Author keywords

Thalassemia; Amplification refractory mutation system; Cascade testing; Genetic counseling; Index case; Polymerase chain reaction

Indexed keywords

HEMOGLOBIN;

ARTICLE; AWARENESS; BETA THALASSEMIA; CHILD; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PAKISTAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BETA-THALASSEMIA; CONSANGUINITY; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MUTATION; PAKISTAN; PEDIGREE; RISK;

EID: 38349079010     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111641     Document Type: Article

References (13)

1. Alwan A, Modell B: Community Control of Genetic and Congenital Disorders. EMRO Technical Publication Series 24. Alexandria, WHO Regional Office for the Eastern Mediterranean, 1997.
2. Ahmad S, Saleem M, Modell B, Petrou M: Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 2002;347:1162-1168.
3. Cao A, Galanello R, Rosatelli MC: Prenatal diagnosis and screening of the haemoglobinopathies. Bail Clin Haematol 1998;11:215-238.
4. Leung KY, Lee CP, Tang MH, Lau ET, Ng LK, Lee YP, Chan HY, Ma ES, Chan V: Cost-effectiveness of prenatal screening for thalassemias in Hong Kong. Prenat Diagn 2004;24:899-907.
5. Premawardhena A, de Silva S, Arambepola M, Olivieri N, Merson L, Muraco J, Allen A, Fisher C, Peto T, Vcihinsky E, Weatherall D: Thalassemia in Sri Lanka: a progress report. Hum Mol Genet 2004;13:203-206.
6. Loukopoulos D: Current status of thalassemia and the sickle cell syndromes in Greece. Semin Hematol 1996;33:76-86.
7. Baig SM, Azhar A, Hassan H, Baig JM, Aslam M, Din MA, Qureshi JA, Zaman T: Prenatal diagnosis of β-thalassemia in Southern Punjab, Pakistan. Prenat Diagn 2006;26:903-905.
8. Baig SM, Azhar A, Din MA, Hassan H, Baig JM, Kiyani A, Rabbi F, Baig SA, Hassan K, Qureshi JA , Zaman T: Spectrum of β-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: establishment of prenatal diagnosis. Haematologica 2006;91:ELT02.
9. Cao A, Galanello R: Effect of consanguinity on screening for thalassemia. N Engl J Med 2002;347: 1200-1202.
10. Baig SM, Rabbi F, Hameed U, Azhar A, Hassan H, Baig JM, Kiyani A, Aminuddin M, Baig SA, Hassan K, Qureshi JA, Zaman T: Molecular characterization of mutations causing β-thalassemia in Faisalabad Pakistan, using the amplification refractory mutation system (ARMS-PCR). Ind J Hum Genet 2005;11:80-83.
11. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF: Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-2516.
12. Baig SM: Molecular diagnosis of β-thalassemia by multiplex ARMS-PCR: a cost effective method for developing countries like Pakistan. Prenat Diagn 2007;27:580-581.
13. Khattak MF, Saleem M: Prevalence of heterozygous β-thalassemia in Northern areas of Pakistan. J Pak Med Assoc 1992;42:32-34.